ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Abiraterone Acetate Trial in African American Prostate Cancer Patients

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Abiraterone Acetate

First Posted Date: 2012-11-28

Last Posted Date: 2017-05-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 11

Registration Number: NCT01735396

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Queens Cancer Center, Queens Hospital, New York, New York, United States

Online Emotional Regulation Group Treatment

Phase 1

Completed

Conditions: Emotional Dysregulation
Executive Dysfunction
Traumatic Brain Injury

Interventions: Behavioral: Online Emotional Regulation Treatment

First Posted Date: 2012-11-21

Last Posted Date: 2015-10-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 147

Registration Number: NCT01730261

Locations: 🇺🇸
The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai, New York, New York, United States

Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy

Not Applicable

Completed

Conditions: Traumatic Brain Injury
Fatigue

Interventions: Device: Bright White Light (BWL)
Device: Dim Red Light (DRL)

First Posted Date: 2012-11-14

Last Posted Date: 2019-08-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 88

Registration Number: NCT01725750

Locations: 🇺🇸
The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai, New York, New York, United States

Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD

Phase 4

Completed

Conditions: ADHD
Attention Deficit Hyperactivity Disorder

Interventions: Drug: Guanfacine Hydrochloride XR
Drug: Placebo

First Posted Date: 2012-10-18

Last Posted Date: 2018-02-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 27

Registration Number: NCT01709695

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Phase 3

Active, not recruiting

Conditions: Squamous Cell Carcinomas

Interventions: Radiation: Reduced Dose Radiation
Radiation: Standard Dose Radiation
Drug: Carboplatin

First Posted Date: 2012-10-15

Last Posted Date: 2024-08-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 23

Registration Number: NCT01706939

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Riluzole in Mild Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: Placebo
Drug: Riluzole

First Posted Date: 2012-10-10

Last Posted Date: 2021-09-22

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 50

Registration Number: NCT01703117

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

Completed

Conditions: X-Linked Protoporphyria
XLP
Erythropoietic Protoporphyria
EPP
XLEPP
XLDP
XLPP
X-Linked Dominant Erythropoietic Protoporphyria

First Posted Date: 2012-09-20

Last Posted Date: 2020-04-17

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 150

Registration Number: NCT01688895

Locations: 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

and more 3 locations

Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach

Phase 4

Completed

Conditions: Attention Deficit Hyperactivity Disorder
ADHD

Interventions: Other: fMRI scans
Drug: Atomoxetine arm
Drug: Methylphenidate arm

First Posted Date: 2012-09-03

Last Posted Date: 2020-07-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 127

Registration Number: NCT01678209

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: isradipine

First Posted Date: 2012-08-06

Last Posted Date: 2018-12-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 11

Registration Number: NCT01658150

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Randomized Controlled Trial of Lung Ultrasound Compared to Chest X-ray for Diagnosing Pneumonia in the Emergency Department

Not Applicable

Completed

Conditions: Pneumonia

Interventions: Radiation: Chest X-Ray
Other: Lung Ultrasound

First Posted Date: 2012-08-01

Last Posted Date: 2017-03-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 191

Registration Number: NCT01654887

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy